Skip to main content
. 2020 Jun 30;2020:3198671. doi: 10.1155/2020/3198671

Table 1.

shows the prevalence of T2DM among participants with a positive family history of T2DM.

Study Sample size PFH population NFH population
Prevalence (%) 95% CI Prevalence (%) 95% CI
Bantie et al. [38] 607 19.2 11.2-29.7 8.9 6.6-11.6
Zenebe et al. [39] 264 35.1 20.2-52.5 15.9 11.4-21.3
Bello-Ovosi et al. [40] 172 35.5 19.2-54.6 22.0 15.5-29.7
Wondemagegn et al. [41] 714 23.1 17.0-30.1 8.1 5.9-10.7
Tesfaye et al. [42] 851 19.6 10.2-32.4 4.2 2.9-5.8
Vuvor et al. [43] 597 14.5 7.2-25.0 2.5 1.3-4.2
Millogo et al. [44] 4415 5.4 2.7-9.4 5.5 4.8-6.2
Abebe et al. [45] 2136 17.9 10.2-28.3 3.1 2.4-3.9
Mayega et al. [46] 1497 20.9 15.2-27.5 15.1 13.2-17.2
Nyenwe et al. [47] 492 26.3 13.4-43.1 5.3 3.4-7.8
Frank et al. [48] 1221 65.0 60.54-69.19 30.7 27.37-34.18
Danquah et al. [49] 1466 66.8 62.86-70.65 32.2 29.16-35.44
Total (random) 14,432 28.2 14.52-44.27 11.2 6.39-17.06
I 2 (inconsistency) = 98.11%, p < 0.0001

PFH: positive family history; NFH: negative family history.